[{"Assets_0_Q3_USD":117787151.0,"CommonStockSharesOutstanding_0_Q3_shares":3532548.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-532235.0,"NetIncomeLoss_1_Q3_USD":125090.0,"NetIncomeLoss_3_Q3_USD":307389.0,"StockholdersEquity_0_Q3_USD":5000006.0,"Ticker":"IMVT","CIK":"1764013","name":"HEALTH SCIENCES ACQUISITIONS CORP","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191113"}]